GlassScriptPhysician profile
Scott L Baranoff
NPI 1356320261
$7,046.14
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $785 · 2020: $291 · 2021: $2,540 · 2022: $1,110 · 2023: $1,984 · 2024: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,990 · Honoraria: $250 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,990.31 |
| Honoraria | $250.00 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,147.77 | 2021-2023 | |
| Astellas Pharma US INC | $1,100.06 | 2019-2024 | Myrbetriq, Xtandi, Veozah |
| Verathon INC. | $800.00 | 2021 | |
| Sumitomo Pharma America, INC. | $656.13 | 2023-2024 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $453.87 | 2019-2024 | Lithovue, Rezum Generator |
| Myriad Genetic Laboratories, INC. | $302.14 | 2021-2024 | Prolaris |
| Myovant Sciences INC. | $297.27 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $264.13 | 2019-2023 | Provenge |
| Cook Incorporated | $250.00 | 2023 | |
| Medtronic, INC. | $189.73 | 2022-2023 | Interstim |
| Neotract INC. | $156.05 | 2019 | |
| Urovant Sciences INC | $144.02 | 2021-2022 | |
| Abbvie INC. | $131.46 | 2023 | Botox, Lupron Depot |
| Endo Pharmaceuticals INC. | $130.85 | 2019-2023 | Xiaflex |
| Blue Earth Diagnostics | $112.02 | 2019-2023 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $102.75 | 2019-2022 | |
| Pfizer INC. | $94.45 | 2022-2024 | |
| 180 Medical, INC. | $83.20 | 2019-2022 | |
| Urogen Pharma, INC. | $71.61 | 2022-2023 | Jelmyto |
| Merck Sharp & Dohme LLC | $62.10 | 2020-2023 | Keytruda, Lynparza |
| Telix Pharmaceuticals | $54.43 | 2024 | Illuccix |
| Accord Healthcare, INC. | $51.19 | 2023-2024 | |
| Antares Pharma, INC. | $50.35 | 2019-2023 | Xyosted, Nocdurna, Tlando |
| Rochester Medical Corporation | $49.98 | 2022 | |
| Ferring Pharmaceuticals INC. | $47.25 | 2019 | |
| Janssen Biotech, INC. | $33.02 | 2019-2023 | Erleada |
| Tolmar Pharmaceuticals, INC. | $30.09 | 2021 | |
| Medtronic USA, INC. | $29.47 | 2020 | |
| Axonics, INC. | $29.00 | 2021-2024 | Axonics, Bulkamid |
| Acerus Pharmaceuticals Corporation | $25.75 | 2020 | |
| Ethicon US, LLC | $24.04 | 2023 | Echelon; Endopath |
| Procept Biorobotics Corporation | $19.85 | 2024 | Aquabeam System |
| Mission Pharmacal Company | $19.73 | 2021 | |
| Amgen INC. | $18.06 | 2023 | Xgeva |
| Kowa Pharmaceuticals America, INC. | $14.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Baranoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.